首页 › 基金 › Fairmount Funds Management LLC › APGE
Fairmount Funds Management LLC 对 APGE 的持仓历史
APOGEE THERAPEUTICS INC
Fairmount Funds Management LLC 在 Q2 2026 的 13F 申报中披露持有 APGE(APOGEE THERAPEUTICS INC)298,647 股,市值约 US$39.6M,约占其申报组合的 2.62%,在其申报持仓中市值排名第 10 位。 Fairmount Funds Management LLC 最近 12 个申报季度中有 12 个季度披露了 APGE 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Fairmount Funds Management LLC 对 APGE 的持仓演变
Fairmount Funds Management LLC 于 Q3 2023 首次披露 APGE 持仓:2,941,176 股(约 US$62.6M)。 该持仓在 Q4 2025 达到峰值 2,048,647 股,市值约 US$154.6M。 在 12 次申报中,Fairmount Funds Management LLC 0 次增持、2 次减持、9 次保持不变。 最近一期申报(Q2 2026)显示持股 298,647 股、市值约 US$39.6M。 持仓曾出现大幅变动:Q1 2024 减持约 30%、Q1 2026 减持约 85%。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 2.94M | $62.65M | 新进 |
| Q4 2023 | 2.94M | $82.18M | 持有 |
| Q1 2024 | 2.05M | $136.13M | 减持 |
| Q2 2024 | 2.05M | $80.61M | 持有 |
| Q3 2024 | 2.05M | $120.34M | 持有 |
| Q4 2024 | 2.05M | $92.80M | 持有 |
| Q1 2025 | 2.05M | $76.54M | 持有 |
| Q2 2025 | 2.05M | $88.97M | 持有 |
| Q3 2025 | 2.05M | $81.39M | 持有 |
| Q4 2025 | 2.05M | $154.63M | 持有 |
| Q1 2026 | 298.65K | $25.14M | 减持 |
| Q2 2026 | 298.65K | $39.64M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 APGE 与 13F 数据
APGE(APOGEE THERAPEUTICS INC)的行业分类暂缺。我们追踪的基金中还有 59 只申报持有 APGE,申报仓位最大的包括:Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$231.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 APGE 的基金
- Venrock Adviser, LLC 8.49M 股 · $1.13B · Q2 2026
- HBK INVESTMENTS L P 2.85M 股 · $378.28M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.74M 股 · $230.96M · Q2 2026
- GLAZER CAPITAL, LLC 1.64M 股 · $217.82M · Q2 2026
- Paradigm Biocapital Advisors LP 1.58M 股 · $209.23M · Q2 2026
- Pentwater Capital Management LP 1.43M 股 · $189.14M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.31M 股 · $173.63M · Q2 2026
- Affinity Asset Advisors, LLC 987.00K 股 · $131.00M · Q2 2026
- First Light Asset Management, LLC 930.29K 股 · $123.48M · Q2 2026
- Kryger Capital LLC 742.55K 股 · $98.56M · Q2 2026
- First Trust Capital Management L.P. 625.18K 股 · $82.98M · Q2 2026
- Remedium Capital Partners, LLC 586.69K 股 · $77.87M · Q2 2026
更多关于 Fairmount Funds Management LLC
常见问题
How long has Fairmount Funds Management LLC held APGE?
Fairmount Funds Management LLC has disclosed APGE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Fairmount Funds Management LLC's current position in APGE?
As of Q2 2026, Fairmount Funds Management LLC holds 298.65K shares of APGE (APOGEE THERAPEUTICS INC), valued at $39.64M, representing 2.62% of its reported portfolio and ranking #10.
Has Fairmount Funds Management LLC been buying or selling APGE?
In the latest 13F filing (Q2 2026), Fairmount Funds Management LLC held unchanged its position in APGE. The position peaked in Q4 2025 at 2.05M shares.
Which other funds hold APGE?
Other major institutional holders of APGE include Venrock Adviser, LLC, HBK INVESTMENTS L P, DRIEHAUS CAPITAL MANAGEMENT LLC, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.